Insider Transactions in Q1 2021 at Voyager Therapeutics, Inc. (VYGR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Allison Dorval Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+21.44%
|
-
|
|
Mar 19
2021
|
Andre Turenne President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+19.88%
|
-
|
|
Mar 19
2021
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+20.93%
|
-
|
|
Mar 19
2021
|
Omar Khwaja Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.01%
|
-
|
|
Feb 16
2021
|
Allison Dorval Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+29.85%
|
-
|
|
Feb 16
2021
|
Robert W. Hesslein Senior VP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
34,000
+28.97%
|
-
|
|
Feb 16
2021
|
Omar Khwaja Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+28.79%
|
-
|
|
Feb 16
2021
|
Andre Turenne President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
94,000
+27.95%
|
-
|
|
Feb 11
2021
|
Omar Khwaja Officer |
SELL
Open market or private sale
|
Direct |
3,475
-6.15%
|
$24,325
$7.55 P/Share
|
|
Feb 11
2021
|
Robert W. Hesslein Senior VP & General Counsel |
SELL
Open market or private sale
|
Direct |
3,186
-6.06%
|
$22,302
$7.55 P/Share
|
|
Feb 11
2021
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,186
-6.49%
|
$22,302
$7.55 P/Share
|
|
Feb 11
2021
|
Andre Turenne President & CEO |
SELL
Open market or private sale
|
Direct |
7,977
-5.1%
|
$55,839
$7.55 P/Share
|
|
Jan 12
2021
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,942
-5.66%
|
$23,536
$8.62 P/Share
|
|
Jan 12
2021
|
Andre Turenne President & CEO |
SELL
Open market or private sale
|
Direct |
10,443
-6.26%
|
$83,544
$8.62 P/Share
|